Cryoport

CYRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$762.083 M

$15.12 +2.79%

Close of 7 Aug 2026

Revenue

$176.2M

#2342 by revenue

Earnings

$78.3M

#1404 by earnings

Shares outstanding

50,649,100

Latest filing cover page

P/E ratio

9.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#178Bright Minds BiosciencesDRUG$778.4M
#179Pharming GroupPHAR$773.3M
#180CryoportCYRX$762.1M
#181CytomX TherapeuticsCTMX$753.3M
#182Rigel PharmaceuticalsRIGL$750.4M

Where these numbers come from

Share counts and financials for Cryoport are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.